08/01/2025
4:15 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:16 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:16 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:16 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:17 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:17 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:17 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:17 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:18 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:18 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:18 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
Get the Latest News and Ratings for SAGE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/01/2025
4:19 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:19 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:19 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:19 PM | Sage Therapeutics (Filer)
| Form S-8 POS | |
08/01/2025
4:21 PM | Sage Therapeutics (Filer)
| Form POSASR | |
08/01/2025
4:21 PM | Sage Therapeutics (Filer)
| Form POSASR | |
08/01/2025
4:21 PM | Sage Therapeutics (Filer)
| Form POSASR | |
08/01/2025
4:22 PM | Sage Therapeutics (Filer)
| Form POSASR | |
07/31/2025
10:57 AM | Benecchi Christopher (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
11:03 AM | Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
11:04 AM | Quirk Michael C. (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
10:17 AM | Greene Barry E (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
10:22 AM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
10:28 AM | FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
10:38 AM | Germano Geno J (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
10:42 AM | Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
10:48 AM | Barrett Elizabeth A. (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
10:52 AM | COLA MICHAEL F (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
8:34 AM | Nasdaq Stock Market LLC (Filed by)
Sage Therapeutics (Subject)
| Form 25-NSE | |
07/31/2025
8:06 AM | Sage Therapeutics (Subject)
SUPERNUS PHARMACEUTICALS, INC. (Filed by)
| Form SC TO-T/A | |
07/31/2025
8:14 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2025
8:17 AM | Sage Therapeutics (Subject)
| Form SC 14D9/A | |
07/30/2025
4:56 PM | BIOGEN INC. (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
07/29/2025
1:32 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
07/28/2025
7:51 AM | Sage Therapeutics (Subject)
| Form SC 14D9/A | |
07/28/2025
7:40 AM | Sage Therapeutics (Subject)
SUPERNUS PHARMACEUTICALS, INC. (Filed by)
| Form SC TO-T/A | |
07/21/2025
8:18 PM | BIOGEN INC. (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
07/21/2025
7:00 AM | Sage Therapeutics (Subject)
| Form SC 14D9/A | |
07/02/2025
4:21 PM | Sage Therapeutics (Subject)
| Form SC 14D9 | |
06/26/2025
3:02 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
GENIUS Act: Cancel Your Money? (Ad) A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control.
Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live. Get the free info kit with 3 strategies to sidestep digital dollar control. |
06/16/2025
4:20 PM | Sage Therapeutics (Subject)
| Form SC14D9C | |
06/16/2025
4:26 PM | Sage Therapeutics (Subject)
SUPERNUS PHARMACEUTICALS, INC. (Filed by)
| Form SC TO-C | |
06/16/2025
10:40 AM | Sage Therapeutics (Subject)
SUPERNUS PHARMACEUTICALS, INC. (Filed by)
| Form SC TO-C | |
06/16/2025
6:55 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2025
3:15 PM | Sage Therapeutics (Filer)
| Form DEF 14A | |
04/24/2025
3:20 PM | Sage Therapeutics (Filer)
| Form DEFA14A | |
04/24/2025
3:25 PM | Sage Therapeutics (Filer)
| Form ARS | |
04/01/2025
4:35 PM | Madison Avenue Partners, LP (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/26/2025
3:36 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
9:01 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/04/2025
3:45 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
8:00 AM | RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
8:30 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
4:16 PM | Sage Therapeutics (Filer)
| Form POS AM | |
02/05/2025
9:41 AM | MORGAN STANLEY (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/31/2025
8:55 AM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
8:28 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
5:02 AM | BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025
5:06 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:34 PM | BIOGEN INC. (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13D | |
12/27/2024
3:11 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
7:47 PM | JONAS JEFFREY M (Reporting)
Sage Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:42 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
5:40 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:14 PM | BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
3:56 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
2:28 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
1:10 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:23 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2024
3:24 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:10 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
3:20 PM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
10:37 AM | Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/17/2024
6:11 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
5:37 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
6:07 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
5:33 AM | Sage Therapeutics (Filer)
| Form S-3ASR | |
Free SAGE Stock Alerts